Summary of WAL MART STORES INC

Item 8.01. Other Events.

Wal-Mart Stores, Inc. (the "Company") and Banc of America Securities LLC, Barclays Capital Inc., J.P. Morgan Securities Inc., and Deutsche Bank Securities Inc., acting for themselves and as representatives of the other several underwriters named in Schedule I to the Pricing Agreement (as defined below) (the "Underwriters"), have entered into a Pricing Agreement, dated January 15, 2009 (the "Pricing Agreement"), pursuant to which, subject to the satisfaction of the conditions set forth therein, the Company has agreed to sell to the Underwriters, and the Underwriters have agreed to purchase from the Company, $500,000,000 aggregate principal amount of the Company's 3.000% Notes Due 2014 (the "2014 Notes") and $500,000,000 aggregate principal amount of the Company's 4.125% Notes Due 2019 (the "2019 Notes" and, together with the 2014 Notes, the "Notes"). The Pricing Agreement incorporates by reference the terms and conditions of an Underwriting Agreement, dated January 15, 2009 (the "Underwriting Agreement"), between the Company and, as to the issuance and sale of the Notes, the Underwriters.

The Company and the Underwriters expect to consummate the sale and purchase of the Notes pursuant to the Pricing Agreement on January 23, 2009. The 2014 Notes will be sold to the public at an aggregate issue price of 99.537% of the principal amount thereof ($497,685,000 in proceeds before underwriting commissions and transaction expenses). The 2019 Notes will be sold to the public at an issue price of 99.561% of the principal amount thereof ($497,805,000 in proceeds before underwriting commissions and transaction expenses). In total, the Notes will be sold to the public at an issue price of $995,490,000. The net proceeds to the Company from the sale of the 2014 Notes, after the underwriting discount, but before transaction expenses of the sale of the 2014 Notes, will be $495,935,000. The net proceeds to the Company from the sale of the 2019 Notes, after the underwriting discount, but before transaction expenses of the sale of the 2019 Notes, will be $495,555,000. In total, the net proceeds to the Company from the sale of the Notes, after the underwriting discount, but before transaction expenses of the sale of the Notes, will be an aggregate of $991,490,000.

The 2014 Notes will constitute part of the Company's newly created series of 3.000% Notes Due 2014 (the "2014 Series"), and the 2019 Notes will constitute part of the Company's newly created series of 4.125% Notes Due 2019 (the "2019 Series" and, together with the 2014 Series, the "New Series"). The Notes of each of the 2014 Series and the 2019 Series will be senior unsecured debt securities of the Company and will rank equally with the other New Series and all of the other senior, unsecured debt obligations of the Company. The 2014 Series and the 2019 Series were created and established, and their terms and conditions were established, by action of the Company and an authorized officer of the Company pursuant to, and in accordance with, the terms of the Indenture, dated as of July 19, 2005, as supplemented (the "Indenture"), between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the "Trustee"). The terms of the 2014 Notes and the 2019 Notes are as set forth in the Indenture and in the forms of the Global Notes (referred to below) that will represent the Notes.

The material terms of the Notes are described in the prospectus supplement of the Company dated January 15, 2009, which relates to the offer and sale of the Notes (the "Prospectus Supplement"), and the Company's prospectus dated January 14, 2009, which prospectus relates to the offer and sale from time to time of an indeterminate amount of the

Company's debt securities (the "Prospectus"). The Prospectus Supplement, together with the Prospectus, was filed by the Company with the Securities and Exchange Commission (the "Commission") on January 20, 2009 pursuant to Rule 424(b)(2) under the U.S. Securities Act of 1933, as amended (the "Securities Act"), in connection with the offer and sale of the Notes. A Final Term Sheet, dated January 15, 2009, relating to the Notes was filed with the Commission pursuant to Rule 433 under the Securities Act on January 15, 2009.

The Notes will be delivered in book-entry form only. The 2014 Notes will be represented by a single global note, in the principal amount of $500,000,000 (the "2014 Global Note"). The 2019 Notes will be represented by a single global note, in the principal amount of $500,000,000 (the "2019 Global Note" and, together with the 2014 Global Note, the "Global Notes"). Each Global Note will be payable to Cede & Co., as nominee of The Depository Trust Company. The Global Notes will be executed by the Company and authenticated by the Trustee in accordance with the Indenture.

Filed as exhibits to this Current Report on Form 8-K are (i) the Pricing Agreement, (ii) the Underwriting Agreement, (iii) the Series Terms Certificate Pursuant to Section 3.01 of the Indenture Relating to 3.000% Notes Due 2014, which was executed in accordance with the Indenture and which evidences the establishment of the terms and conditions of the 2014 Series in accordance with the Indenture, (iv) the Series Terms Certificate Pursuant to Section 3.01 of the Indenture Relating to 4.125% Notes Due 2019, which was executed in accordance with the Indenture and which evidences the establishment of the terms and conditions of the 2019 Series in accordance with the Indenture, (v) the form of the 2014 Global Note, (vi) the form of the 2019 Global Note and (vii) the opinion of Andrews Kurth LLP, counsel to the Company, regarding the legality of the Notes.

The Company is offering and selling the Notes under the Company's Registration Statement on Form S-3 (File No. 333-156724), which registration statement relates to the offer and sale on a delayed basis from time to time of an indeterminate amount of the Company's debt securities. This Current Report on Form 8-K is being filed in connection with the offer and sale of the Notes as described herein and to file with the Commission in connection with the Registration Statement the documents and instruments attached hereto as exhibits.